Zimmermann Spring 2027 Ready-to-Wear

STAT+: Lilly’s Jaypirca approved as first-line CLL therapy

Eli Lilly’s Jaypirca has won FDA approval for previously untreated chronic lymphocytic leukemia and small lymphocytic ly…

This Credit Card-Sized E-Reader Is 15% Off for October Prime Day

The early Prime Big Deal Days flash sale ends tonight.

STAT+: Pharmalittle: We’re reading about a Vaxcyte pneumococcal shot, increasing pharma M&A, and mor…

Vaxcyte said its pneumococcal vaccine hit the primary endpoints in a Phase 3 clinical trial, setting up a competition wi…